Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers
2011

Using Plasma MicroRNA to Diagnose Lung Cancer in Patients with Solitary Pulmonary Nodules

Sample size: 156 publication Evidence: moderate

Author Information

Author(s): Shen Jun, Liu Ziling, Todd Nevins W, Zhang Howard, Liao Jipei, Yu Lei, Guarnera Maria A, Li Ruiyun, Cai Ling, Zhan Min, Jiang Feng

Primary Institution: University of Maryland School of Medicine

Hypothesis

Can plasma microRNAs serve as effective biomarkers for identifying lung cancer in individuals with solitary pulmonary nodules detected by CT scans?

Conclusion

Plasma microRNAs can potentially serve as noninvasive biomarkers for diagnosing lung cancer in patients with solitary pulmonary nodules.

Supporting Evidence

  • The study identified three microRNAs that can distinguish malignant from benign solitary pulmonary nodules with high sensitivity and specificity.
  • The combined use of miR-21, miR-210, and miR-486-5p yielded an area under the curve of 0.855 in distinguishing lung tumors from benign SPNs.
  • Validation in a testing set confirmed the diagnostic value of the microRNA panel.

Takeaway

Doctors can use special molecules in the blood called microRNAs to help tell if a lung bump is cancer or not, which can help catch cancer early.

Methodology

The study involved a training set of 32 patients with malignant SPNs, 33 with benign SPNs, and 29 healthy smokers, followed by validation in a testing set of 76 malignant and 80 benign SPNs, using quantitative reverse transcriptase PCR to analyze plasma microRNA levels.

Limitations

The study's findings are based on a limited number of microRNA candidates, and the heterogeneity of malignant SPNs may affect the results.

Participant Demographics

{"training_set":{"malignant":{"count":32,"median_age":66.2,"sex_distribution":{"female":12,"male":20}},"benign":{"count":33,"median_age":64.7,"sex_distribution":{"female":13,"male":20}},"healthy_smokers":{"count":29,"median_age":66.5,"sex_distribution":{"female":10,"male":19}}},"testing_set":{"malignant":{"count":76,"median_age":67.9,"sex_distribution":{"female":34,"male":42}},"benign":{"count":80,"median_age":65.4,"sex_distribution":{"female":30,"male":50}}}}

Statistical Information

P-Value

p ≤ 0.001

Statistical Significance

p ≤ 0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-11-374

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication